A diabetes drug which has skyrocketed in popularity after being hailed as a weight loss solution should not be given to new patients amid a worldwide shortage, Australia’s medicines regulator has announced. The Therapeutic Goods Administration said that it had been recently advised by Novo Nordisk, the company which makesContinue Reading